Maitri

About Maitri

Maitri Medicinals operates as a vertically integrated medical cannabis company within Pennsylvania's regulated market, engaging in the cultivation, production, and retail of medicinal cannabis products. The company was founded in 2016 by Corinne Ogrodnik and Joseph Vesely, third-generation Southwestern Pennsylvania residents, who were motivated by personal wellness experiences and a desire to serve patients in their home region. Ogrodnik's background includes teaching public policy and working on an organic farm, while Vesely was an operations researcher for the RAND Corporation and has experience in indoor microgreens cultivation. Their journey into the cannabis industry began before Pennsylvania legalized medical marijuana in 2016, spurred by Ogrodnik's own positive results with cannabis for a medical condition.

The company's business model is rooted in direct-to-patient sales through its dispensaries, serving individuals with qualifying medical conditions as defined by state law. Its first dispensary opened in Uniontown in 2018, followed by locations in Pittsburgh and Greensburg. In October 2025, the Greensburg location was relocated to New Stanton to offer enhanced patient accessibility, including a drive-thru service. Maitri's revenue is generated from the sale of a wide array of medical marijuana products, which patients can purchase using cash or debit cards. The company secured one of the initial 12 competitive grower/processor licenses awarded by the state, enabling it to control its supply chain from cultivation to retail. Funding milestones include a Series A round of $6.87 million in February 2019 and a subsequent raise of nearly $18 million in late 2022, bringing its total known funding to over $24 million.

Under its Maitri Genetics subsidiary, the firm cultivates a diverse library of cannabis strains, including proprietary and legacy strains, in small batches to ensure quality. Its product offerings are comprehensive, including flower, vapes, concentrates (like shatter, wax, and live resin), tinctures, topicals, and capsules. The business strategy emphasizes patient education, providing consultations with licensed pharmacists and medical advisors to guide patients on product selection, administration, and dosage for symptom management. By operating within Pennsylvania's medical-only market, which has grown to over $1.4 billion in annual sales, Maitri targets a registered patient base that exceeds one million people statewide.